Clinical Trial Update: A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. [Phase 2]

View source ↗

Summary

Phase II study of a dose-dense AC regimen (fluorouracil, epirubicin, cyclophosphamide) with filgrastim support, followed by weekly paclitaxel in women with prim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Women With Primary Breast Cancer | Phase 2 | Status: COMPLETED